Merck already scored an FDA nod in March with the breakthrough biologic Winrevair, a first-in-class treatment for pulmonary arterial hypertension. Importantly, the approval doesn’t restrict ...
The analyst lowered expectations for Januvia, Bridion, and ex-US Winrevair, while increasing ... by in-licensing a preclinical oral small molecule, GLP-1RA HS-10535, from Hansoh Pharma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback